SCHEMBL6003300

SCHEMBL6003300

COc1ccc2c(C(=O)c3ccc(OCCC4CCCCCN4)cc3)c(-c3ccc(F)cc3F)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.43
ESR1 P03372 7/20 0.37
ESR2 Q92731 7/20 0.37
LTA4H P09960 1/20 0.37
SSTR2 P30874 4/20 0.37
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
PHLPP2 Q6ZVD8 1/20 0.35
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
NQO2 P16083 1/20 0.35
PTGER2 P43116 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
LTB4R Q15722 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
KDM2B Q8NHM5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003394 0.99 CHEK2 (0.43) CHEK2ESR1ESR2LTA4HSSTR2
SCHEMBL6005363 0.94 CHEK2 (0.42) CHEK2ESR1ESR2LTA4HSSTR2
SCHEMBL6003307 0.94 CHEK2 (0.43) CHEK2ESR1ESR2LTA4HSSTR2
SCHEMBL6004724 0.93 CHEK2 (0.43) CHEK2ESR1ESR2SSTR2CYP1A2
SCHEMBL6005515 0.92 CHEK2 (0.42) CHEK2ESR1ESR2LTA4HSSTR2
SCHEMBL6004611 0.92 CHEK2 (0.43) CHEK2ESR1ESR2LTA4HSSTR2
SCHEMBL6003358 0.91 CHEK2 (0.43) CHEK2ESR1ESR2LTA4HSSTR2
SCHEMBL6005357 0.91 CHEK2 (0.43) CHEK2ESR1ESR2LTA4H
SCHEMBL6004626 0.90 CHEK2 (0.44) CHEK2ESR1ESR2LTA4H
SCHEMBL6005446 0.90 CHEK2 (0.44) CHEK2ESR1ESR2LTA4HSSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed